PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: IMARC Group

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Indian Immunodiagnostics Market to Reach US$ 264 Million by 2016 Finds IMARC Group - IMARC Group has recently released one of the most comprehensive market studies on the Indian Immunodiagnostics market - IMARCgroup.com
Indian Immunodiagnostics Market to Reach US$ 264 Million by 2016 Finds IMARC Group

 

NewswireToday - /newswire/ - Noida, Uttar Pradesh, India, 2012/03/05 - IMARC Group has recently released one of the most comprehensive market studies on the Indian Immunodiagnostics market - IMARCgroup.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

IMARC Group, one of the world’s leading research and advisory firms, in its latest report “Indian Diagnostic & Therapeutic Antibodies Market Report & Forecast: 2011-2016” finds that the Indian Immunodiagnostics market is expected to grow robustly in the coming years and reach revenues worth INR 11,881 million (US$ 264 million) by 2016. The study, that has been undertaken using desk-based as well as qualitative primary market research provides and draws upon a comprehensive analysis of the Indian Immunodiagnostics market.

Key Segments Analyzed
Understanding the strengths, weaknesses, opportunities and challenges in the Indian Immunodiagnostics market

Understanding the technological considerations and regulatory factors in the Indian Immunodiagnostics market
• Evaluating the various types of Immunodiagnostic tests conducted in India and analyzing their strengths and weaknesses
• Understanding the key regulations for registering, manufacturing and importing diagnostics in India

Comprehensive situation analysis of the Indian Immunodiagnostics market
Segments covered: HIV, Hepatitis B, Hepatitis C, Tuberculosis, Dengue, Syphilis and Cancer

Focus of the analysis in each segment:
• Number of tests conducted each year
• Breakup by type of tests conducted
• Current and future market sales
• Average cost of diagnostic tests
• Key players operating in the market

Key Questions Answered in this Report:
• What is the current size and growth of the Indian Immunodiagnostics market?
• What are the most popular types of Immunodiagnostic tests conducted in India?
• What are the most popular indications for which Immunodiagnostic tests are conducted?
• Who are the key players operating in the Indian Immunodiagnostics market?
• What are the various regulations in the Indian Immunodiagnostics market?
• What are the strengths, weaknesses, opportunities and threats in the Indian Immunodiagnostics Market?
• What is the prevalence of Elisa and Rapid tests for each Indication?
• What is the future of Immunodiagnostics in India?
• What is the current and future landscape of HIV diagnostics in India?
• What is the current and future landscape of Hepatitis B diagnostics in India?
• What is the current and future landscape of Hepatitis C diagnostics in India?
• What is the current and future landscape of Tuberculosis diagnostics in India?
• What is the current and future landscape of Dengue diagnostics in India?
• What is the current and future landscape of Syphilis diagnostics in India?
• What is the current and future landscape of Cancer diagnostics in India?

To obtain the complete report, please contact:

IMARC Group Asia
E: apac[.]imarcgroup.com - P: +91-120-425-6531

IMARC Group North America
E: america[.]imarcgroup.com - P: +1-631-791-1145.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: IMARC Group

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Indian Immunodiagnostics Market to Reach US$ 264 Million by 2016 Finds IMARC Group

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Krishna Sharma - IMARCgroup.com 
+91 12 04155099 press[.]imarcgroup.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any IMARC Group securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From IMARC Group / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

FDA Approves Genentech’s Actemra (Tocilizumab) for Giant Cell Arteritis
BTG and HealthLoop Collaborate on IO Loop™ - An Exclusive Service to Connect Patients and Interventional Oncologists throughout Treatment
BD and UniteOR Join Forces to Deliver an Integrated Tracking Solution for the Operating Room Setting
MDxHealth and Maastricht University Collaborate on Next Generation (Epi)genetic Cancer Diagnostics
BD to Invest $60 Million in Nebraska Manufacturing Facility
MDxHealth Announces New Contract with MediNcrease Health Plans Regarding ConfirmMDx and SelectMDx
Pulse Certified As A Level Four Multichannel Content Agency by Veeva
Earthly Mist - Opioid-Alternative Painkiller, Kratom Now Available in Oklahoma City
MDxHealth and Exact Sciences Sign Collaboration Agreement
BD Advances Efforts to Combat Antimicrobial Resistance with Enhanced Diagnostic Solution Offering
First European Patients Treated with DC Bead LUMI™ Radiopaque Drug-Eluting Beads
FDA Approves Genentech’s Lucentis (Ranibizumab Injection) for Diabetic Retinopathy
Biopharmaceutical Analytical Instrumentation Market Garners Strong Opportunities from Double-digit Growth in Biosimilars Finds Frost & Sullivan
BD Completes Acquisition of Caesarea Medical Electronics
MDxHealth and Ghent University Ink Licensing and Collaboration Agreements to Develop Cancer Biomarker Visualization Technology

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  BizJobs.com

Visit  Deb Sheppard - Medium Psychic Author Speaker





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)